KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cintas (CTAS) Capital Expenditures (2016 - 2025)

Cintas' Capital Expenditures history spans 16 years, with the latest figure at $106.3 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 4.77% year-over-year to $106.3 million; the TTM value through Nov 2025 reached $422.8 million, up 4.83%, while the annual FY2025 figure was $408.9 million, 0.14% changed from the prior year.
  • Capital Expenditures for Q4 2025 was $106.3 million at Cintas, up from $102.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $114.6 million in Q2 2025 and bottomed at $42.8 million in Q1 2021.
  • The 5-year median for Capital Expenditures is $93.4 million (2023), against an average of $84.2 million.
  • The largest YoY upside for Capital Expenditures was 123.58% in 2021 against a maximum downside of 32.37% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $59.9 million in 2021, then grew by 27.57% to $76.4 million in 2022, then grew by 22.83% to $93.8 million in 2023, then increased by 8.08% to $101.4 million in 2024, then grew by 4.77% to $106.3 million in 2025.
  • Per Business Quant, the three most recent readings for CTAS's Capital Expenditures are $106.3 million (Q4 2025), $102.0 million (Q3 2025), and $114.6 million (Q2 2025).